{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T17:04:51Z","timestamp":1790528691291,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20151096"],"award-info":[{"award-number":["BK20151096"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Projects of Nanjing Health and Family Planning Commission","award":["ZKX17015"],"award-info":[{"award-number":["ZKX17015"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ygyno.2019.04.005","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T12:26:58Z","timestamp":1554812818000},"page":"207-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT\/mTOR\/4E-BP1 pathway"],"prefix":"10.1016","volume":"154","author":[{"given":"Xiaofeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.04.005_bb0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1097-2765(00)80299-3","article-title":"NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities","volume":"2","author":"Xue","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/35050532","article-title":"Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor","volume":"3","author":"Mazumdar","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0015","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/onc.2010.608","article-title":"TGF-\u03b21 signaling targets metastasis-associated protein 1, a new effector in epithelial cells","volume":"30","author":"Pakala","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0020","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10555-014-9525-1","article-title":"MTA1\u2014a stress response protein: a master regulator of gene expression and cancer cell behavior","volume":"33","author":"Wang","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.seminoncol.2003.08.005","article-title":"Emerging roles of MTA family members in human cancers","volume":"30","author":"Kumar","year":"2003","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0030","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1074\/jbc.R600029200","article-title":"Metastasis tumor antigens, an emerging family of multifaceted master coregulators","volume":"282","author":"Manavathi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.22124","article-title":"Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma","volume":"47","author":"Soo","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-014-0330-z","article-title":"Expression of MTA1 in nasopharyngeal carcinoma and its correlation with prognosis","volume":"31","author":"Yuan","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0045","series-title":"Adv. Cancer Res","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2015.04.005","article-title":"Unravelling the complexity and functions of MTA coregulators in human cancer","author":"Li","year":"2015"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0050","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3892\/ol.2015.3395","article-title":"Endocrine MPA enhances the effects of TAC chemotherapy on improvement of prognosis and increase in long-term survival rates for patients with endometrial cancer","volume":"10","author":"YUAN","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0055","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.humpath.2006.01.024","article-title":"Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas","volume":"37","author":"Balasenthil","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0060","first-page":"807","article-title":"microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1","volume":"27","author":"Hu","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0065","doi-asserted-by":"crossref","first-page":"e90810","DOI":"10.1371\/journal.pone.0090810","article-title":"Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer","volume":"9","author":"Kong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0075","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00432-008-0529-5","article-title":"Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro","volume":"135","author":"Darb-Esfahani","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0080","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1158\/1078-0432.CCR-12-0662","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in endometrial cancer","volume":"18","author":"Slomovitz","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0085","doi-asserted-by":"crossref","first-page":"22958","DOI":"10.1016\/S0021-9258(17)31603-4","article-title":"A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses","volume":"269","author":"Toh","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lungcan.2018.07.040","article-title":"Relationship between MTA1 and spread through air space and their joint influence on prognosis of patients with stage I-III lung adenocarcinoma","volume":"124","author":"Liu","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0095","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.prp.2018.02.011","article-title":"Metastasis-associated protein 1 (MTA1) in gastric cancer tissues is positively associated with poorer prognosis","volume":"214","author":"Lv","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0100","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.humpath.2011.05.002","article-title":"Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study","volume":"43","author":"Prisco","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.15252\/msb.20167144","article-title":"Gene-specific correlation of RNA and protein levels in human cells and tissues","volume":"12","author":"Edfors","year":"2016","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0110","first-page":"1447","article-title":"The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas","volume":"25","author":"Br\u00fcning","year":"2010","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0115","article-title":"The metastasis-associated gene MTA3, a component of the Mi-2\/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma","volume":"8","author":"Dong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0120","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4161\/cbt.7.9.6427","article-title":"The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO","volume":"7","author":"Dannenmann","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0092-8674(03)00234-4","article-title":"MTA3, a Mi-2\/NuRD complex subunit, regulates an invasive growth pathway in breast cancer","volume":"113","author":"Fujita","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2559.2011.04103.x","article-title":"The metastasis-associated gene MTA3 is an independent prognostic parameter in uterine non-endometrioid carcinomas","volume":"60","author":"Mylonas","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0135","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-09-0898","article-title":"MicroRNA-661, a c\/EBP target, inhibits metastatic tumor antigen 1 and regulates its functions","volume":"69","author":"Reddy","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0140","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1038\/onc.2016.491","article-title":"MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0145","doi-asserted-by":"crossref","first-page":"21825","DOI":"10.18632\/oncotarget.7989","article-title":"MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2","volume":"7","author":"Fan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0150","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.biopha.2016.08.058","article-title":"MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1","volume":"83","author":"Pan","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0155","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/abbs\/gmv039","article-title":"miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion","volume":"47","author":"Zhang","year":"2015","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","article-title":"Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E","volume":"17","author":"Hsieh","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0165","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10555-014-9517-1","article-title":"Molecular functions and significance of the MTA family in hormone-independent cancer","volume":"33","author":"Ning","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3545","article-title":"Metastasis-associated protein 1 is an integral component of the circadian molecular machinery","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0175","doi-asserted-by":"crossref","first-page":"27843","DOI":"10.1074\/jbc.M112.348474","article-title":"Metastasis-associated protein 1\/histone deacetylase 4-nucleosome remodeling and deacetylase complex regulates phosphatase and tensin homolog gene expression and function","volume":"287","author":"Reddy","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0180","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1158\/0008-5472.CAN-10-0909","article-title":"Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressor","volume":"70","author":"Kumar","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0185","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.molcel.2012.12.016","article-title":"A core chromatin remodeling factor instructs global chromatin signaling through multivalent Reading of nucleosome codes","volume":"49","author":"Nair","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ygyno.2019.04.005_bb0190","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1073\/pnas.1101193108","article-title":"Multiple coregulatory control of tyrosine hydroxylase gene transcription","volume":"108","author":"Reddy","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0195","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1158\/0008-5472.CAN-12-3998","article-title":"MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer","volume":"73","author":"Pakala","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbamcr.2014.11.004","article-title":"Resveratrol regulates PTEN\/Akt pathway through inhibition of MTA1\/HDAC unit of the NuRD complex in prostate cancer","volume":"1853","author":"Dhar","year":"2015","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0500","first-page":"989","article-title":"\u03b2-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1","volume":"6","author":"Chen","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0505","doi-asserted-by":"crossref","first-page":"699","DOI":"10.14348\/molcells.2014.0029","article-title":"MTA1 overexpression induces cisplatin resistance in nasopharyngeal carcinoma by promoting cancer stem cells properties","volume":"37","author":"Feng","year":"2014","journal-title":"Mol. Cells."},{"key":"10.1016\/j.ygyno.2019.04.005_bb0510","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/cam4.1209","article-title":"Targeting MTA1\/HIF-1 \u03b1 signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression","volume":"6","author":"Butt","year":"2017","journal-title":"Cancer Med."}],"updated-by":[{"DOI":"10.1016\/j.ygyno.2023.11.035","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819305001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819305001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T15:45:06Z","timestamp":1663256706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819305001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0090825819305001"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.04.005","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ygyno.2023.11.035","asserted-by":"object"}]},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT\/mTOR\/4E-BP1 pathway","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}